GNMSF
GENMAB A/S DKK
stockOTC
EODSep 28, 2026
355.00USD+0.567%(+2.00)100
Loading…
Loading…
23.48B
Healthcare
Biotechnology
HQ
Copenhagen, Koebenhavn V, Denmark
1,846
Previous Close
$353.00
Beta
-1.00
52-Week High
$355.00 2026-09-28
52-Week Low
$232.34 2026-06-02
SMA 50
$291.84
SMA 200
$265.48
Avg. Vol 10D
221
Avg. Vol 30D
1,755
Avg. Vol 90D
3,526
Relative Vol
0.06
66.14M
60.64M
191,429
0.32%
47.36
GNMSF Profile
founded in 1999, genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. partnering of selected product candidates and technologies is a key focus of genmab's strategy and the company has alliances with top tier pharmaceutical and biotechnology companies. disclaimer: bit.ly/gendisclaimer
GNMSF Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1M | 329.25 | 2026-09-04 | +7.82% | -1.037 |
| 3M | 282.16 | 2026-07-06 | +25.82% | -0.870 |
| 6M | 261.30 | 2026-04-06 | +35.86% | -1.158 |
| 1Y | 330.00 | 2025-10-03 | +7.58% | -0.998 |
| 2Y | 237.28 | 2024-10-04 | +49.61% | — |
| 5Y | 418.78 | 2021-10-04 | -15.23% | 0.113 |
GNMSF Stock Summary
GENMAB A/S DKK (OTC:GNMSF) stock price today is $355.00, and today's volume is 100. GNMSF is up 0.567% today. The 30 day average volume is 1,755. GNMSF market cap is $23.48B with 66.14M shares outstanding.